Related Experiment Video
Updated: Mar 9, 2026
04:33
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
1.6K
Cognitive Behavioural Therapy for Insomnia in Psychiatric Disorders
Markus Jansson-Fröjmark1, Annika Norell-Clarke2
1Department of Psychology, Stockholm University, SE-106 91 Stockholm, Sweden.
Current Sleep Medicine Reports
|December 23, 2016
Summary
Cognitive Behavioural Therapy for Insomnia (CBT-I) effectively treats sleep issues and improves psychiatric symptoms in patients with comorbid anxiety, depression, bipolar disorder, PTSD, and psychotic disorders.
Area of Science:
- Psychiatry and Sleep Medicine
Background:
- Insomnia, characterized by difficulties initiating or maintaining sleep, is frequently comorbid with psychiatric disorders.
- Historically viewed as secondary, comorbid insomnia is now recognized as an independent condition requiring dedicated treatment.
- Comorbid insomnia is linked to more severe psychiatric symptoms, highlighting the need for effective interventions.
Approach:
- This article reviews recent studies investigating the impact of Cognitive Behavioural Therapy for Insomnia (CBT-I) on sleep, daytime functioning, and psychiatric comorbidities.
- The review focuses on patient groups diagnosed with anxiety, depression, bipolar disorder, psychotic disorders, and post-traumatic stress disorder.
- Methodological advancements in CBT-I research for comorbid psychiatric populations are also discussed.
Key Points:
- CBT-I demonstrates efficacy in improving sleep quality and duration for individuals with comorbid insomnia.
- Treatment with CBT-I has shown positive effects on daytime symptoms, including mood, anxiety levels, and overall functioning.
- Evidence suggests CBT-I can lead to significant reductions in psychiatric symptomology across various disorders.
Conclusions:
- CBT-I is a valuable therapeutic option for managing insomnia in patients with psychiatric comorbidities.
- Further research is needed to optimize CBT-I protocols and explore its long-term effects in diverse psychiatric populations.
- The findings support the integration of CBT-I into routine clinical practice for individuals experiencing comorbid insomnia and psychiatric conditions.
More Related Videos
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
6.2K
05:34Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
3.7K
Related Concept Videos
01:27Insomnia
563
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
563
01:19Management of Insomnia
747
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
747
01:25Cognitive Therapy
1.4K
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.4K
01:14CNS Depressants: Barbiturates and Benzodiazepines
1.6K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.6K
01:24Rational Emotive Behavior Therapy
581
Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert...
581
01:26Psychosis: Goals of Pharmacotherapy
646
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
646